ES419603A1 - Pharmaceutical preparations containing pyrazolones - Google Patents

Pharmaceutical preparations containing pyrazolones

Info

Publication number
ES419603A1
ES419603A1 ES419603A ES419603A ES419603A1 ES 419603 A1 ES419603 A1 ES 419603A1 ES 419603 A ES419603 A ES 419603A ES 419603 A ES419603 A ES 419603A ES 419603 A1 ES419603 A1 ES 419603A1
Authority
ES
Spain
Prior art keywords
pyrazolones
tablets
pharmaceutical preparations
preparations containing
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES419603A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Farbwerke Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG, Farbwerke Hoechst AG filed Critical Hoechst AG
Publication of ES419603A1 publication Critical patent/ES419603A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Process for the production of mechanically stable and resistant tablets that contain one or more pyrazolones and possibly caffeine compounds, said tablets being relatively small with respect to the dosage of active substances, characterized in that polyethylene glycols 2000 to 20000 are added as the predominant auxiliary substance in concentrations between 5 and 40% and optionally a lubricating agent, and the mixture, optionally after prior granulation, is compressed into tablets. (Machine-translation by Google Translate, not legally binding)
ES419603A 1972-10-19 1973-10-13 Pharmaceutical preparations containing pyrazolones Expired ES419603A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2251199A DE2251199C3 (en) 1972-10-19 1972-10-19 Process for the preparation of tablets containing pyrazolones

Publications (1)

Publication Number Publication Date
ES419603A1 true ES419603A1 (en) 1976-07-01

Family

ID=5859451

Family Applications (1)

Application Number Title Priority Date Filing Date
ES419603A Expired ES419603A1 (en) 1972-10-19 1973-10-13 Pharmaceutical preparations containing pyrazolones

Country Status (10)

Country Link
JP (1) JPS5217086B2 (en)
AT (1) AT343817B (en)
BE (1) BE806290A (en)
DE (1) DE2251199C3 (en)
DK (1) DK144872C (en)
ES (1) ES419603A1 (en)
FR (1) FR2247207B1 (en)
GB (1) GB1446237A (en)
NL (1) NL180477C (en)
ZA (1) ZA738102B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0243521A1 (en) * 1986-04-30 1987-11-04 Werner Prof. Dr. Thorn Preparation for oral administration
TW284688B (en) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
JP2682353B2 (en) * 1991-11-20 1997-11-26 武田薬品工業株式会社 Oral pharmaceutical composition and method for producing the same

Also Published As

Publication number Publication date
DK144872B (en) 1982-06-28
ATA884773A (en) 1977-10-15
AT343817B (en) 1978-06-26
DE2251199A1 (en) 1974-05-02
FR2247207A1 (en) 1975-05-09
NL7314098A (en) 1974-04-23
NL180477B (en) 1986-10-01
DE2251199B2 (en) 1979-08-09
DK144872C (en) 1982-11-15
JPS4971131A (en) 1974-07-10
BE806290A (en) 1974-04-19
FR2247207B1 (en) 1978-11-03
JPS5217086B2 (en) 1977-05-13
GB1446237A (en) 1976-08-18
NL180477C (en) 1987-03-02
DE2251199C3 (en) 1980-04-10
ZA738102B (en) 1975-05-28

Similar Documents

Publication Publication Date Title
ES439113A1 (en) Pharmaceutical compositions
ES264040A1 (en) Pharmaceutical formulations and their manufacture
ES312728A1 (en) Procedure for the preparation of compresses by compression of dust mixtures. (Machine-translation by Google Translate, not legally binding)
HU173465B (en) Process for preparing thieno-benzoxepine-acetic acid derivatives and pharmaceutical preparations containing these compounds as active substances
NO813826L (en) Pain-degrading drug presses
ES370952A1 (en) Rumen stable medicament and/or nutrient compositions
ES328453A1 (en) Method and apparatus for aggloming solid pulverulent substances in a fluidized base. (Machine-translation by Google Translate, not legally binding)
DE2963990D1 (en) Analgesic tablet and process for its preparation
SE7610595L (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION OF INSULINŸ FOR RECTAL USE
ES425514A1 (en) Coumarin derivatives for the treatment of allergies
HU175933B (en) Process for producing 4-hydroxy-3,5-dialkyl-phenyl-propionic acid derivatives and pharmaceutical compositions containing ttem as active agents
ES410825A1 (en) Quinoline derivatives
ES419603A1 (en) Pharmaceutical preparations containing pyrazolones
ES449797A1 (en) 1,3,8-triazaspiro(4.5)decan-4-one derivatives
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
ES279358A1 (en) Procedure for preparing insecticide compositions to apply to the walls (Machine-translation by Google Translate, not legally binding)
ES283585A1 (en) A procedure for the preparation of a therapeutic composition (Machine-translation by Google Translate, not legally binding)
NL7416691A (en) PROCEDURE FOR THE PREPARATION OF 17(ALPHA)-ACYLOXY-21-OXYPREGNANES, AS WELL AS PHARMACEUTICAL PRE- AND CONTAINING THESE COMPOUNDS AS ACTIVE COMMON.
ES377723A1 (en) Improvements in pharmaceutical compositions
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
GB841633A (en) Pharmaceutical composition for use in treatment of helminths
JPS51123834A (en) A medicine against the headache
HU175305B (en) Process for preparing new bicycloheptene derivatives and pharmaceutical preparations containing such compounds as active materials
GB884576A (en) Pharmaceutical compositions comprising an alkylamino substituted barbituric acid and salts thereof
AU227098B2 (en) Pellets for supplying biologically active substances to ruminants